These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20441013)

  • 1. [Evaluation of disease management programmes--assessing methods and initial outcomes from a health economic perspective].
    Birnbaum DS; Braun S
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(2):85-91. PubMed ID: 20441013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Introduction of disease management programmes in Germany as reflected by differing interests of health insurance companies and the federal association of statutory health insurance physicians].
    Erler A
    Gesundheitswesen; 2002 Nov; 64(11):572-7. PubMed ID: 12442215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease management programs in Germany: Validity of the medical documentation].
    Linder R; Horenkamp-Sonntag D; Engel S; Köppel D; Heilmann T; Verheyen F
    Dtsch Med Wochenschr; 2014 Jan; 139(1-2):19-22. PubMed ID: 24062021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A systematic review on population-based indicators of the quality of care in formal and informal provider networks and their application in health economic evaluations].
    Seibert K; Stiefler S; Domhoff D; Wolf-Ostermann K; Peschke D
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():7-23. PubMed ID: 31327735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of quality assurance programmes for inpatient care in Germany: a literature review].
    Khan C; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(10):576-86. PubMed ID: 25499110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The German guideline clearing-project on bronchial asthma-part 1: Methodology and results of formal appraisal].
    Thole H; Weingart O; Lampert U; Bassler D; Fessler J; Forster J; Franzen D; Geraedts M; Kroegel C; Mörike K; Schmitz M; Scholz R; Teske S; Ollenschläger G;
    Pneumologie; 2003 Aug; 57(8):459-67. PubMed ID: 12928987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health economic evaluation of disease management programs].
    Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):34-9. PubMed ID: 16320012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Points of view: the role of quality measurement from the Federal Joint Committee's perspective].
    Klakow-Franck R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):456-64. PubMed ID: 25523843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. German diabetes management programs improve quality of care and curb costs.
    Stock S; Drabik A; Büscher G; Graf C; Ullrich W; Gerber A; Lauterbach KW; Lüngen M
    Health Aff (Millwood); 2010 Dec; 29(12):2197-205. PubMed ID: 21134920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does telemonitoring lead to health and economic benefits in patients with chronic heart failure? - a systematic review].
    Augustin U; Henschke C
    Gesundheitswesen; 2012 Dec; 74(12):e114-21. PubMed ID: 22615027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disease management programs: Difficulties in the analysis of benefit].
    Linder R; Horenkamp-Sonntag D; Bestmann B; Battmer U; Heilmann T; Verheyen F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):345-51. PubMed ID: 25708909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germany's disease management program: improving outcomes in congestive heart failure.
    Kottmair S; Frye C; Ziegenhagen DJ
    Health Care Financ Rev; 2005; 27(1):79-87. PubMed ID: 17288080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The quality of chronic care in Germany].
    Fullerton B; Nolte E; Erler A
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):554-62. PubMed ID: 22142877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods in health services research. The example of the evaluation of the German disease management programmes].
    Morfeld M; Wirtz M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Feb; 49(2):120-9. PubMed ID: 16418821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor].
    Hoffmann F; Icks A
    Gesundheitswesen; 2012 May; 74(5):291-7. PubMed ID: 21755492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated care programmes for chronically ill patients: a review of systematic reviews.
    Ouwens M; Wollersheim H; Hermens R; Hulscher M; Grol R
    Int J Qual Health Care; 2005 Apr; 17(2):141-6. PubMed ID: 15665066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of medical rehabilitation in disease management programmes].
    Lüngen M; Lauterbach KW
    Rehabilitation (Stuttg); 2003 Oct; 42(5):284-9. PubMed ID: 14551831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT.
    Hofmann R; Völler H; Nagels K; Bindl D; Vettorazzi E; Dittmar R; Wohlgemuth W; Neumann T; Störk S; Bruder O; Wegscheider K; Nagel E; Fleck E;
    Trials; 2015 Aug; 16():343. PubMed ID: 26259568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.